We accept
Obesity is a chronic and complex disease that challenges millions of people worldwide. For many seeking an effective and lasting solution, tirzepatide emerges as a revolutionary medication. This comprehensive guide invites you to discover its remarkable effectiveness in treating obesity, understanding the scientific mechanisms that make it such a powerful and promising tool.
Let's detail the basis of its action, the results that prove it, and what you need to know about this transformative treatment.
—
The effectiveness of Tirzepatide lies in its innovative molecular architecture, which acts comprehensively on the biological mechanisms that lead to excess weight. It is a dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual action is key to its success, as it mimics and amplifies the function of gut hormones that the body naturally produces and that are essential for weight and metabolism control.
Unveiling the Detailed Mechanism of Action:
Tirzepatide acts on the appetite control centers in the brain (especially the hypothalamus), sending potent signals that significantly reduce hunger and intense food cravings ("food noise"). This reveals a biological truth: the struggle against constant hunger is lessened, making it easier to adhere to a calorie-restricted diet.
It amplifies the feeling of satiety and fullness after meals, making the patient feel satisfied with smaller portions and for longer.
The medication slows down the rate at which food leaves the stomach.
This reveals how satiety is prolonged, contributing to reduced calorie intake throughout the day and helping with adherence to healthy eating habits.
Increased Fat Oxidation: Recent scientific research (such as that from the Pennington Biomedical Research Center published in Cell Metabolism in April 2025) reveals that tirzepatide not only decreases appetite but also increases fat burning (fat oxidation) for energy. This means the body becomes more efficient at using its fat reserves, directly attacking one of the pillars of obesity.
Combating Metabolic Slowdown: Crucially, these same studies suggest that Tirzepatide can mitigate the natural slowdown of metabolism that occurs during weight loss. This unlocks one of the biggest challenges in weight maintenance, as it combats the biological mechanism that often leads to weight regain, promoting long-term sustainability.
Improved Insulin Sensitivity: Tirzepatide improves how your body handles insulin, optimizing cell response. This results in better control of blood sugar levels and more efficient glucose utilization, reducing fat storage and combating insulin resistance, a common characteristic in obesity.
Weight loss with tirzepatide is predominantly fat mass, with a notable preservation of muscle mass. This leads to healthier and more functional weight loss, vital for metabolic health and strength.
—
The effectiveness of tirzepatide in the treatment of obesity is solidly proven by rigorous Phase 3 clinical studies (the SURMOUNT program), considered the gold standard of medical research and published in the most prestigious scientific journals.
Average and Impressive Weight Loss Results:
In the SURMOUNT-1 study (participants without Type 2 diabetes), tirzepatide led to an average weight loss ranging from 15% to 22.5% of their initial body weight over 72 weeks (approx. 1 year and 6 months) at the highest doses (10 mg and 15 mg). This translates to an average reduction of 16 kg to over 24 kg. These results unveil a new level of effectiveness for drug treatments of obesity.
In the SURMOUNT-5 study (direct comparison with Semaglutide – Wegovy), published in The New England Journal of Medicine on May 11, 2025, Tirzepatide demonstrated an average weight loss of 20.2% of body weight, significantly greater than the 13.7% observed with Semaglutide at 72 weeks. This reveals its superiority in efficacy.
Long-Term Sustainability:
Long-term analyses of the studies (presented at the European Congress on Obesity – ECO in May 2025) reveal that tirzepatide can promote clinically significant and sustainable weight loss for at least 3 years. Approximately two-thirds of participants managed to maintain most of the weight lost during this period. This demonstrates its potential to offer a lasting fight against obesity.
Additional Health Benefits (Obesity Comorbidities):
In addition to weight loss, studies show that tirzepatide improves cardiometabolic markers such as blood pressure, cholesterol levels (triglycerides and LDL), and glycemic control (HbA1c). Recent research (ACC.25 in March 2025) indicated improved renal function and cardiovascular outcomes in patients with obesity and heart failure. This reveals a treatment that goes beyond the scale.
—
Tirzepatide is a prescription medication and its use must be strictly monitored by a healthcare professional. In Brazil, its approved indication by ANVISA is for the treatment of Type 2 Diabetes. However, physicians, based on robust scientific evidence and global clinical practice, may prescribe it "off-label" (outside the formal indication in the package insert) for patients with obesity or overweight and comorbidities, if they deem it clinically appropriate.
Eligibility Criteria (generally considered, based on internationally approved guidelines for weight):
Adults with a BMI (Body Mass Index) of 30 kg/m² or higher (obesity).
Adults with a BMI of 27 kg/m² or higher (overweight) who have at least one weight-related comorbidity.
Thorough Medical Evaluation: A complete medical evaluation is essential to verify health history, laboratory tests, and identify contraindications (such as a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 – MEN2).
Administration: Weekly subcutaneous injections, which the patient can administer at home with a pre-filled pen, under medical guidance.
Gradual Dose Escalation (Titration): Treatment always begins with the lowest dose and is gradually increased (every 4 weeks) under the guidance of a physician. This process is crucial to allow the body to adapt and minimize side effects (nausea, diarrhea, constipation), ensuring adherence and continuity.
Side Effects: Primarily gastrointestinal. They are more common at the beginning and during dose escalation, but are generally transient and manageable.
—
Tirzepatide is a high-cost medication in Brazil. The price can vary depending on the dosage and the pharmacy.
Average Cost: In 2024, the price of a box containing 4 pens (for 1 month of treatment) of Mounjaro (Tirzepatide) could range from R$ 900 to R$ 1,500 or more, depending on the dose and place of purchase. These values are for reference only and may be adjusted in 2025.
Access: Available at pharmacies with a prescription. Coverage by health insurance plans is more common for the approved indication (Type 2 Diabetes).
—
The medical community in Brazil emphasizes that tirzepatide is a powerful tool, but its effectiveness is maximized and sustained when combined with a holistic approach.
Balanced and Low-Calorie Diet: Medication facilitates adherence to a healthy diet, but working with a nutritionist is essential for a personalized and sustainable meal plan.
Regular Physical Activity: Complements the action of the medication, contributing to fat burning and muscle preservation, as well as improving overall health.
Behavioral Support: Addressing emotional triggers, managing stress, and optimizing sleep are crucial for building lasting healthy habits.
Continuous Medical Monitoring: Essential for monitoring progress, adjusting doses, and ensuring the patient's health.
—
Conclusion: Tirzepatide – A Discovery that Transforms the Treatment of Obesity
Tirzepatide unveils a new chapter in the treatment of obesity, offering unprecedented efficacy and proven results. By acting comprehensively on the biological mechanisms of hunger, satiety, and metabolism, it drives significant weight loss, predominantly of fat, while maintaining muscle mass and providing important additional health benefits. For eligible patients in Brazil, under strict medical supervision and as part of a comprehensive weight management program, Tirzepatide is a promising and transformative solution in the effective fight against obesity.
| Monday | 09:00 - 17:00 |
| Tuesday | 09:00 - 17:00 |
| Wednesday | 09:00 - 17:00 |
| Thursday | 09:00 - 17:00 |
| Friday | 09:00 - 17:00 |
| Saturday | 09:00 - 17:00 |
| Sunday | Closed |